Navigation Links
Inovio: DNA delivery technology shows positive human results

assessing safety, tolerability, and cellular (T-cell) and humoral (antibody) immune responses to a novel plasmid-based cancer vaccine delivered using Inovio’s proprietary DNA delivery technology. In each of the two arms of this study, i.e. with and without electroporation-enhanced delivery, three patient groups are being treated using escalating dosage levels. A total of 24 patients have been treated out of a total objective of 30 patients.

An analysis of interim data from the first and partially from the second dose treatment groups demonstrated the following points:

1. Electroporation appears safe and it is well tolerated.

2. The number of patients with significant antibody responses was four of 10 in the patient groups treated without electroporation compared to nine of 10 in the patient groups treated with electroporation.

3. The magnitude of the antibody response was significantly higher in patients treated using electroporation. Data on the T-cell response is being compiled.

The investigators continue to enroll and treat patients in the higher-dosage treatment groups.

“These data demonstrate for the first time in a clinical trial that the significant enhancement in potency of a gene- based vaccine delivered by electroporation in animals can also be seen in humans,” said Dr. Christian Ottensmeier, clinical investigator of the study.

“Achieving validation that the compelling pre-clinical data generated by Inovio and partners in large animal models can be achieved in humans is a key milestone for Inovio,” stated Avtar Dhillon, MD, Inovio’s CEO. “These results suggest that Inovio’s electroporation DNA delivery technology may provide an important alternative to viral and other DNA delivery technologies and could play a profound role in safely augmenting the immune response generated by future prophylactic and therapeutic immunot
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
2. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
3. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
4. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
5. Prana Biotechnology Presents New Key Findings on PBT2
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ASCO Annual Meeting
7. Generex Biotechnology Vaccine Strategy Presented at International Conference in London
8. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting
9. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
10. Santaris Pharma presents positive preclinical data on SPC2996 at the American Association for Cancer Research
11. Antisoma plc (UK) - Second lung cancer trial adds to positive data on AS1404
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Inovio DNA delivery technology shows positive human results
(Date:7/22/2014)... , July 22, 2014 /PRNewswire-iReach/ -- The ... basis of application, technology, portability, product, end user, ... to register the highest growth rate in the ... period. This high growth is attributed to technological ... Chest imaging accounted for the largest share of ...
(Date:7/22/2014)... 2014  Edwards Lifesciences Corporation (NYSE: EW ... valves and hemodynamic monitoring, announced that Edwards, Chairman and ... an expert panelist at the invitation of the United ... discuss medical device innovation at its hearing, "21 st ... and Communication." "Edwards has five decades of ...
(Date:7/22/2014)... , July 22, 2014 Cumberland Pharmaceuticals ... second quarter 2014 financial results after the market closes ... live Internet webcast will be held on Tuesday, August ... the results. To participate in the call, ... international callers).  A rebroadcast of the teleconference will be ...
Breaking Medicine Technology:Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 2Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 3Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 4Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 5Edwards' CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation 2Cumberland Pharmaceuticals To Announce Second Quarter 2014 Financial Results On August 5, 2014 2
... 1, 2011 Health Diagnostic Laboratory Inc. (HDL, ... to develop a novel laboratory developed test with ... diagnostic test and surgical therapy solutions for the ... coronary heart disease (CHD) and stroke are responsible ...
... Radiation Therapy Services Holdings, Inc. ("Radiation Therapy") announced ... International, Inc., has acquired Medical Developers, LLC ("MDLLC"), ... treatment facilities in Latin America. The ... of $47.5 million in cash, $16.25 million in ...
Cached Medicine Technology:Health Diagnostic Laboratory, Inc. (HDL, Inc.) Partners With Gamma Therapeutics to Offer Breakthrough Diagnostic Assay for Heart Attack and Stroke Risk 2Health Diagnostic Laboratory, Inc. (HDL, Inc.) Partners With Gamma Therapeutics to Offer Breakthrough Diagnostic Assay for Heart Attack and Stroke Risk 3Radiation Therapy Services Holdings, Inc. Acquires Medical Developers, LLC 2Radiation Therapy Services Holdings, Inc. Acquires Medical Developers, LLC 3
(Date:7/22/2014)... (WASHINGTON, July 22, 2014) The American Society of ... Vanderbilt University School of Medicine, and Robert P. Hebbel, ... the 2014 Ernest Beutler Lecture and Prize for their ... disease. , The Ernest Beutler Lecture, named for the ... and physician-scientist for more than 50 years, is a ...
(Date:7/22/2014)... If you,re a member of the Clean Plate Club ... you,re not alone! A new Cornell University study ... or she puts on his or her plate. ... your stomach," says Brian Wansink Ph.D., author of the forthcoming ... the Cornell Food and Brand Lab. , Wansink and co-author ...
(Date:7/22/2014)... Feldman says women are often in the dark. Historically, it ... data has shown that post-menopausal women are just as likely ... to be adequately diagnosed and treated. New research from Western ... of Clinical Pharmacology brings to light a genetic basis ... women are more prone to heart disease. , The study, ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Legislation ... Seniors Access to Local Pharmacies Act of 2014”) ... Part D would undermine the availability of lower ... by $21 billion over the next 10 years, ... released by the Pharmaceutical Care Management Association (PCMA). ...
(Date:7/22/2014)... July 22, 2014 SIMpalm, ... updated payment app for Forte Payment System. Forte Mobile ... ACH payments on iPhone, iPod and iPad. The ... been recently updated by SIMpalm. This update was for ... currently supported on iOS 4.3 and is available to ...
Breaking Medicine News(10 mins):Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 2Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 4Health News:Gene variant identified as a heart disease risk factor for women 2Health News:PCMA: New Study Finds H.R. 4577 to Cost $21 Billion Over 10 Years 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 3
... Life-span facts have always been shrouded in ambiguity, though ... calories and longevity. // Now, a novel report has ... a bearing on the influences of calorie restriction and ... Andrezej Bartke from Southern Illinois University in Springfield and ...
... and indulging in a Mediterranean diet, which is based on a ... longevity and good health, highlights a new study conducted by the ... 30 minutes a day can add five years to your life. ... tally, reported THE online edition of Daily Mail. Similarly, people who ...
... patients with head and neck cancer have some unique ... screening test for this highly aggressive cancer. // ... head and neck cancer to 68 healthy controls revealed ... researchers say. ,‘We found scores and scores ...
... of their value on Wednesday after the company reported disappointing ... C virus. // ,The shares of ... the heavy morning trade on the Nasdaq. ,The ... from the second stage of a trial involving the antisense ...
... 150 people which included some AIDS sufferers, held protests ... to patent its anti-HIV drug, Tenofovir, in India. // ... local production of the generic equivalent. ,The ... patent on the drug tenofovir. The drug has been ...
... to place babies to sleep on their backs to reduce ... number of children with 'flat head syndrome'. // ... 'dangerous practice' of babies sleeping on their front or side. ... the official advice on the best way to avoid sudden ...
Cached Medicine News:Health News:Protein Expression to Serve as Marker for Head and Neck Cancer 2Health News:Protein Expression to Serve as Marker for Head and Neck Cancer 3Health News:AIDS Sufferers Protest against Proposed Patent for Tenofovir 2Health News:Fear Of Flat head Syndrome Makes Parents Ignore Advice About Cot Death 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: